Picture of Sensorion SA logo

ALSEN — Sensorion SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Sensorion Announces 5.6 Million Euros Non-Dilutive Funding To Support SENS-401 Phase 2 Study

Dec 23 (Reuters) - Sensorion SA  ALSEN.PA :
    * SENSORION ANNOUNCES €5.6M NON-DILUTIVE FUNDING TO SUPPORT
SENS-401 PHASE 2 STUDY IN SUDDEN SENSORINEURAL HEARING LOSS;
FRENCH MINISTRY OF ARMED FORCES TO PARTICIPATE IN THE STUDY
    * FRENCH MINISTRY OF ARMED FORCES WILL PERMIT FRENCH
MILITARY
PERSONNEL EXPOSED TO IMPULSE NOISE DURING THEIR PROFESSIONAL
ACTIVITIES TO VOLUNTEER TO PARTICIPATE IN THIS CLINICAL STUDY
    * SENSORION IS LEADING A CONSORTIUM INCLUDING FRENCH ARMY
BIOMEDICAL RESEARCH CENTER (IRBA), INSTITUT PASTEUR AND
ELECTRONIQUE DU MAZET
    * FINANCING IS CONDITIONED UPON EXECUTION OF A FINANCING
AGREEMENT
WITH BPIFRANCE WITHIN THREE MONTHS

Source text for Eikon:  ID:nBw4pH2VLa 
Further company coverage:  ALSEN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))

Recent news on Sensorion SA

See all news